Literature DB >> 3299437

Baseline characteristics of 10-day placebo washout responders in antidepressant trials.

J G Rabkin, J W Stewart, P J McGrath, J S Markowitz, W Harrison, F M Quitkin.   

Abstract

In antidepressant drug trials, the randomized treatment phase is usually preceded by a single-blind placebo period or "washout." Ninety-four depressed patients who improved during this 10-day placebo period constitute our study focus. Analysis of baseline and postplacebo measures showed that the 10-day placebo responders in our sample were convincingly depressed at baseline and improved significantly after placebo washout. This group of patients differed from 6-week placebo responders in our randomized trials in being more mildly ill, being more chronic, containing fewer cases of primary depression, and having fewer illness precipitants. They differed from placebo nonresponders largely in manifesting milder illness symptoms across the range of psychopathology. The proportion of placebo washout responders declined in the winter months.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3299437     DOI: 10.1016/0165-1781(87)90057-6

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  5 in total

1.  Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.

Authors:  B Saletu; N Brandstätter; M Metka; M Stamenkovic; P Anderer; H V Semlitsch; G Heytmanek; J Huber; J Grünberger; L Linzmayer
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

2.  A comparison of placebo responders and nonresponders in subgroups of depressive disorder.

Authors:  R J Bialik; A V Ravindran; D Bakish; Y D Lapierre
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

3.  A new strategy for antidepressant prescription.

Authors:  Francis Lavergne; Thérèse M Jay
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

Review 4.  Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysis.

Authors:  Irene Bighelli; Anna Borghesani; Corrado Barbui
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

5.  Multiple Sclerosis, Melatonin, and Neurobehavioral Diseases.

Authors:  Richard Wurtman
Journal:  Front Endocrinol (Lausanne)       Date:  2017-10-23       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.